Abriil 22, war wanaagsan ayaa yimid!Hebei Veyong Pharmaceutical Co., Ltd. ayaa mar kale si guul leh u heshay shahaadada CEP ee EUivermectinAPI ay soo saartay Wakaaladda Yurub ee Tayada Daawooyinka (EDQM).
IvermectinAPI waa mid ka mid ah alaabada ugu muhiimsan ee Veyong Pharma.Waxaa si fiican u soo dhaweeyay macaamiisha gudaha iyo dibaddaba sababtoo ah xasillooni xooggan, tayada sare leh iyo habka wax soo saarka cagaaran.2018, waxay si guul leh u heshay shahaadada FDA ee Maraykanka.
Shahaadada ivermectin CEP waa shahaadada la qabsiga Pharmacopoeia ee Yurub, taas oo aan aqoonsanayn dhammaan wadamada xubnaha ka ah Midowga Yurub, laakiin sidoo kale waxaa aqoonsan dalal badan oo aqoonsan heerka Pharmacopoeia Yurub.Helitaanka shahaadada CEP mar labaad waa aqoonsiga badeecadaha Veyong Pharma ee suuqyada caalamiga ah, qaabka tartanka suuqa ee Veyong, iyo calaamad muhiim ah oo lagu gaadho horumar ganacsi oo tayo sare leh oo laga sameeyo suuqyada dibadda.
Waqtiga boostada: Abriil-28-2022